IDEXX Laboratories, Inc. logo
IDEXX Laboratories, Inc. (IDXX)
Compare

IDEXX Laboratories, Inc. (IDXX) EV/FCF Ratio: 42.75x

Is IDEXX Laboratories, Inc.’s EV/FCF ratio high or low?

IDEXX Laboratories, Inc.'s EV/FCF ratio of 42.75x is 35% below its 5-year average of 65.95x, near the low end of its 5-year range (38.21x–111.13x).

As of Sunday, June 14, 2026. 24.04% below its 12-month average of 56.28x.

IDXX EV/FCF Ratio Chart

IDXX EV/FCF Ratio
42.75x-18.73% 1Y
Zoom

IDXX Average EV/FCF Ratio Chart

IDXX Current vs Average EV/FCF Ratio Chart

IDXX EV/FCF Ratio Metrics

EV/FCF RATIO

42.75x

EV/FCF RATIO AVG TTM

56.28x

EV/FCF RATIO AVG 3Y

56.87x

EV/FCF RATIO AVG 5Y

65.95x

EV/FCF RATIO AVG 10Y

69.17x

EV/FCF RATIO AVG 15Y

60.16x

EV/FCF RATIO AVG 20Y

54.56x

CURRENT VS TTM AVG

-24.04%

CURRENT VS 3Y AVG

-24.83%

CURRENT VS 5Y AVG

-35.18%

CURRENT VS 10Y AVG

-38.19%

CURRENT VS 15Y AVG

-28.94%

CURRENT VS 20Y AVG

-21.65%

IDXX Competitors' EV/FCF Ratio

NAMEMARKET CAPEV/FCF RATIOTTM3Y5Y
IDEXX Laboratories, Inc. (IDXX)$44.24B42.75x56.28x56.87x65.95x
Humana Inc. (HUM)vs ›$45.53B43.08x33.75x21.63x31.66x
Agilent Technologies, Inc. (A)vs ›$36.67B30.59x34.61x30.04x33.45x
Becton, Dickinson and Company (BDX)vs ›$52.98B18.30x23.34x27.93x30.73x
Cencora, Inc. (COR)vs ›$54.80B41.83x34.50x22.64x19.61x
Zoetis Inc. (ZTS)vs ›$33.36B19.15x28.04x41.96x48.22x
Centene Corporation (CNC)vs ›$32.19B4.32x9.55x24.73x19.03x
Medline Inc. (MDLN)vs ›$30.96B26.63x27.74x27.74x27.74x
IQVIA Holdings Inc. (IQV)vs ›$30.29B17.65x19.84x27.23x27.81x
Biogen Inc. (BIIB)vs ›$29.53B12.53x12.73x21.62x21.16x

Cash Flow Valuation Comparison

EV/FCF

42.8x

P/FCF

41.9x

FCF Yield

2.39%

Formula: EV/FCF = Enterprise Value / Free Cash Flow

EV/FCF vs P/FCF:

  • EV/FCF accounts for debt and cash through enterprise value
  • P/FCF only considers equity value
  • EV/FCF can be compared across companies with different debt levels
  • Both measure how the market values cash generation

IDEXX Laboratories, Inc. EV/FCF Ratio Formula & Definition

EV/FCF = Enterprise Value / Free Cash Flow (TTM)

Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

IDEXX Laboratories, Inc. EV/FCF Ratio FAQ

What is the EV/FCF ratio for IDEXX Laboratories, Inc. (IDXX)?
The EV/FCF ratio for IDXX stock is 42.75x.
Is IDEXX Laboratories, Inc.'s EV/FCF ratio high or low?
IDEXX Laboratories, Inc.'s EV/FCF ratio of 42.75x is 35% below its 5-year average of 65.95x, near the low end of its 5-year range (38.21x–111.13x).
What is the TTM average EV/FCF ratio for IDEXX Laboratories, Inc. (IDXX)?
The TTM average EV/FCF ratio for IDXX stock is 56.28x.
What is the 3Y average EV/FCF ratio for IDEXX Laboratories, Inc. (IDXX)?
The 3Y average EV/FCF ratio for IDXX stock is 56.87x.
What is the 5Y average EV/FCF ratio for IDEXX Laboratories, Inc. (IDXX)?
The 5Y average EV/FCF ratio for IDXX stock is 65.95x.
What is the 10Y average EV/FCF ratio for IDEXX Laboratories, Inc. (IDXX)?
The 10Y average EV/FCF ratio for IDXX stock is 69.17x.
What is the 15Y average EV/FCF ratio for IDEXX Laboratories, Inc. (IDXX)?
The 15Y average EV/FCF ratio for IDXX stock is 60.16x.
What is the 20Y average EV/FCF ratio for IDEXX Laboratories, Inc. (IDXX)?
The 20Y average EV/FCF ratio for IDXX stock is 54.56x.

IDEXX Laboratories, Inc. EV/FCF Ratio History

DATEEV/FCF RATIO
2026-06-1242.75x
2026-06-1142.52x
2026-06-1042.45x
2026-06-0944.09x
2026-06-0842.77x
2026-06-0542.84x
2026-06-0443.03x
2026-06-0342.74x
2026-06-0241.99x
2026-06-0143.19x
2026-05-2942.94x
2026-05-2843.28x
2026-05-2742.01x
2026-05-2642.47x
2026-05-2242.63x
2026-05-2142.16x
2026-05-2042.20x
2026-05-1941.67x
2026-05-1841.62x
2026-05-1540.35x
2026-05-1440.65x
2026-05-1340.34x
2026-05-1240.73x
2026-05-1140.59x
2026-05-0842.69x
2026-05-0743.59x
2026-05-0644.12x
2026-05-0542.90x
2026-05-0443.98x
2026-05-0144.31x
2026-04-3043.80x
2026-04-2943.25x
2026-04-2844.38x
2026-04-2744.88x
2026-04-2444.19x
2026-04-2343.81x
2026-04-2245.15x
2026-04-2144.43x
2026-04-2045.51x
2026-04-1745.98x
2026-04-1644.50x
2026-04-1545.33x
2026-04-1445.58x
2026-04-1344.81x
2026-04-1043.97x
2026-04-0945.64x
2026-04-0846.18x
2026-04-0744.87x
2026-04-0645.08x
2026-04-0244.47x
2026-04-0144.10x
2026-03-3143.88x
2026-03-3043.52x
2026-03-2743.61x
2026-03-2644.76x
2026-03-2544.94x
2026-03-2444.52x
2026-03-2345.16x
2026-03-2045.06x
2026-03-1945.26x
2026-03-1845.05x
2026-03-1745.81x
2026-03-1645.76x
2026-03-1344.80x
2026-03-1244.60x
2026-03-1146.84x
2026-03-1046.72x
2026-03-0947.60x
2026-03-0647.45x
2026-03-0548.25x
2026-03-0450.53x
2026-03-0349.53x
2026-03-0249.61x
2026-02-2751.15x
2026-02-2651.45x
2026-02-2551.20x
2026-02-2450.57x
2026-02-2348.57x
2026-02-2049.53x
2026-02-1954.31x
2026-02-1854.66x
2026-02-1753.92x
2026-02-1354.19x
2026-02-1253.17x
2026-02-1155.83x
2026-02-1055.65x
2026-02-0955.08x
2026-02-0655.48x
2026-02-0555.40x
2026-02-0455.34x
2026-02-0354.47x
2026-02-0255.06x
2026-01-3057.67x
2026-01-2958.20x
2026-01-2859.13x
2026-01-2759.73x
2026-01-2659.99x
2026-01-2359.65x
2026-01-2259.41x
2026-01-2159.87x
2026-01-2058.99x
2026-01-1661.47x
2026-01-1561.20x
2026-01-1461.06x
2026-01-1361.36x
2026-01-1262.27x
2026-01-0961.30x
2026-01-0861.22x
2026-01-0761.40x
2026-01-0660.75x
2026-01-0558.67x
2026-01-0257.63x
2025-12-3158.19x
2025-12-3058.68x
2025-12-2959.15x
2025-12-2659.20x
2025-12-2459.17x
2025-12-2358.67x
2025-12-2260.35x
2025-12-1960.20x
2025-12-1859.93x
2025-12-1759.80x
2025-12-1659.59x
2025-12-1560.22x
2025-12-1260.53x
2025-12-1160.81x
2025-12-1060.33x
2025-12-0960.09x
2025-12-0860.73x
2025-12-0561.36x
2025-12-0461.65x
2025-12-0362.36x
2025-12-0262.94x
2025-12-0162.62x
2025-11-2864.64x
2025-11-2664.91x
2025-11-2565.81x
2025-11-2464.58x
2025-11-2162.36x
2025-11-2059.27x
2025-11-1959.93x
2025-11-1857.65x
2025-11-1757.55x
2025-11-1459.32x
2025-11-1360.30x
2025-11-1261.32x
2025-11-1161.23x
2025-11-1060.98x
2025-11-0760.89x
2025-11-0661.33x
2025-11-0561.88x
2025-11-0462.04x
2025-11-0362.11x
2025-10-3167.23x
2025-10-3067.13x
2025-10-2967.04x
2025-10-2867.74x
2025-10-2769.10x
2025-10-2468.42x
2025-10-2368.18x
2025-10-2267.68x
2025-10-2168.03x
2025-10-2068.68x
2025-10-1767.85x
2025-10-1668.05x
2025-10-1568.24x
2025-10-1468.00x
2025-10-1367.63x
2025-10-1065.83x
2025-10-0967.15x
2025-10-0867.27x
2025-10-0767.00x
2025-10-0667.05x
2025-10-0367.41x
2025-10-0267.68x
2025-10-0166.25x
2025-09-3068.21x
2025-09-2967.34x
2025-09-2667.51x
2025-09-2566.04x
2025-09-2466.99x
2025-09-2369.20x
2025-09-2268.76x
2025-09-1970.02x
2025-09-1869.95x
2025-09-1768.42x
2025-09-1668.92x
2025-09-1568.75x
2025-09-1268.45x
2025-09-1168.87x
2025-09-1068.11x
2025-09-0969.96x
2025-09-0869.67x
2025-09-0568.64x
2025-09-0468.37x
2025-09-0367.70x
2025-09-0268.27x
2025-08-2969.07x
2025-08-2869.06x
2025-08-2768.42x
2025-08-2668.51x
2025-08-2568.47x
2025-08-2268.91x
2025-08-2167.60x
2025-08-2068.31x
2025-08-1967.98x
2025-08-1868.10x
2025-08-1569.46x
2025-08-1469.79x
2025-08-1370.83x
2025-08-1269.61x
2025-08-1169.59x
2025-08-0870.22x
2025-08-0769.38x
2025-08-0666.67x
2025-08-0568.53x
2025-08-0472.80x
2025-08-0153.44x
2025-07-3153.32x
2025-07-3057.02x
2025-07-2957.11x
2025-07-2856.47x
2025-07-2556.34x
2025-07-2454.85x
2025-07-2353.94x
2025-07-2253.10x
2025-07-2152.01x
2025-07-1851.39x
2025-07-1751.80x
2025-07-1651.98x
2025-07-1552.57x
2025-07-1453.04x
2025-07-1153.23x
2025-07-1053.98x
2025-07-0953.94x
2025-07-0853.76x
2025-07-0754.42x
2025-07-0354.56x
2025-07-0254.14x
2025-07-0154.14x
2025-06-3053.52x
2025-06-2753.03x
2025-06-2652.68x
2025-06-2552.94x
2025-06-2452.95x
2025-06-2352.38x
2025-06-2052.30x
2025-06-1851.91x
2025-06-1751.98x
2025-06-1652.78x
2025-06-1352.19x
2025-06-1252.60x
2025-06-1152.33x
2025-06-1052.50x
2025-06-0951.78x
2025-06-0652.40x
2025-06-0552.14x
2025-06-0452.40x
2025-06-0352.49x
2025-06-0251.41x

Showing the most recent 260 of 4,826 data points. The chart above shows the full history.

About IDEXX Laboratories, Inc.

IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments. For companion animals, IDEXX offers a comprehensive suite of point-of-care veterinary diagnostic tools, such as instruments, consumables, and rapid assay kits. It also provides reference laboratory diagnostic and consultation services, alongside practice management and diagnostic imaging solutions for veterinarians. Furthermore, the company supports the biomedical research community with health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services. In the livestock, poultry, and dairy markets, IDEXX supplies diagnostic and health-monitoring solutions. Its water testing portfolio includes products designed to detect various microbiological contaminants, notably the Colilert, Colilert-18, and Colisure tests for total coliforms and E. coli, as well as Enterolert, Pseudalert, Filta-Max, Filta-Max xpress, Legiolert, and Quanti-Tray products. Beyond these, IDEXX extends its reach to human point-of-care medical diagnostics, offering electrolyte and blood gas analyzers, and SARS-CoV-2 RT-PCR tests. Other key offerings encompass in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers, as well as SNAP rapid assay test kits. Veterinary software and services for both independent clinics and large corporate veterinary groups are also part of its offerings. The company distributes its extensive product and service catalog through its own dedicated marketing, customer service, sales, and technical service teams, supplemented by independent distributors and other resellers. IDEXX Laboratories, Inc. was established in 1983 and maintains its headquarters in Westbrook, Maine.

Westbrook, ME
11,000 employees
Healthcare / Medical - Diagnostics & Research
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Jonathan J. Mazelsky